Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
The Journal of Biological Chemistry|January 21, 2023
Loss of fatty acid binding protein 3 ameliorates lipopolysaccharide-induced inflammation and endothelial dysfunctionHien C Nguyen, Shuhan Bu, Sepideh Nikfarjam, et al.
The Journal of Clinical Psychiatry|December 23, 1998
The treatment of chronic depression, part 1: study design and rationale for evaluating the comparative efficacy of sertraline and imipramine as acute, crossover, continuation, and maintenance phase therapiesA J Rush, L M Koran, M B Keller, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2015
Brief report: enrichment of activated group 3 innate lymphoid cells in psoriatic arthritis synovial fluidEmmerik F A Leijten, Tessa S van Kempen, Marianne Boes, et al.
Colloids and Surfaces. B, Biointerfaces|June 14, 2016
A surface modification of clozapine-loaded nanocapsules improves their efficacy: A study of formulation development and biological assessmentSimone M Vieira, Luana R Michels, Katiane Roversi, et al.
The Journal of Clinical Psychiatry|December 23, 1998
The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramineM B Keller, A J Gelenberg, R M Hirschfeld, et al.
Sleep|June 5, 2013
Observer variation in drug-induced sleep endoscopy: experienced versus nonexperienced ear, nose, and throat surgeonsAnneclaire V M T Vroegop, Olivier M Vanderveken, Kristien Wouters, et al.
Cancer Chemotherapy and Pharmacology|May 18, 2020
CD73 as a target to improve temozolomide chemotherapy effect in glioblastoma preclinical modelJ H Azambuja, R S Schuh, L R Michels, et al.
American Heart Journal|September 1, 1999
Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trialM Spiecker, J Windeler, F Vermeer, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 2020
Blockade of CD73 delays glioblastoma growth by modulating the immune environmentJ H Azambuja, R S Schuh, L R Michels, et al.
Molecular Neurobiology|August 14, 2019
Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical ApproachJ H Azambuja, R S Schuh, L R Michels, et al.
Pageof 16